QuantLogix ← DGX scorecard
📅 DGX Earnings Preview
Quest Diagnostics Inc.
Next report (est.)
01/22/2027
Countdown
86 days
EPS growth YoY
+28.7%
Revenue growth YoY
+10.0%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
10/23/2026 ±4.1% -0.6% over-priced
07/23/2026 ±2.8% +8.6% under-priced
04/22/2026 ±3.0% -0.5% over-priced
02/26/2026 ±2.0% +1.6% over-priced
10/21/2025 ±1.5% -3.0% under-priced
07/23/2025 ±2.8% -4.3% under-priced
04/23/2025 ±3.5% +0.4% over-priced
02/20/2025 ±2.2% +0.2% over-priced
Across these reports, options implied an average ±2.7% move vs an actual average of 2.4% — the stock stayed inside the implied band 63% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q3 FY2026 $2.78 $3.1B $312M
Q2 FY2026 $2.84 $3.0B $320M
Q1 FY2026 $2.24 $2.9B $252M
Q4 FY2025 — $2.8B $245M
Analyst posture
Buy / Strong Buy
13
Hold
10
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 59/100 Full scorecard →
Get alerted before every DGX report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on DGX before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Quest Diagnostics Inc. (DGX) reports in 86 days, with the next report estimated for 01/22/2027. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 2.4% on average — the market has been roughly fair on DGX's earnings risk. Fundamentals into the print: EPS up 28.7% year-over-year, revenue up 10.0%. QuantLogix's live 5-factor engine currently reads DGX as a buy at 59/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →